Can GLP-1 receptor agonists improve crude outcomes associated with heart failure? A meta-analysis of randomized controlled trials comprising 78,806 patients

被引:0
|
作者
Kumric, M. Marko [1 ]
Urlic, H. [1 ]
Kurir, T. Ticinovic [2 ]
Vilovic, M. [1 ]
Glavas, D. [2 ]
Duplancic, D. [2 ]
Bozic, J. [1 ]
机构
[1] Univ Split, Sch Med, Split, Croatia
[2] Univ Hosp Ctr Split, Split, Croatia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:313 / 313
页数:1
相关论文
共 50 条
  • [31] Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
    Sattar, Naveed
    Lee, Matthew M. Y.
    Kristensen, Soren L.
    Branch, Kelley R. H.
    Del Prato, Stefano
    Khurmi, Nardev S.
    Lam, Carolyn S. P.
    Lopes, Renato D.
    McMurray, John J., V
    Pratley, Richard E.
    Rosenstock, Julio
    Gerstein, Hertzel C.
    LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (10): : 653 - 662
  • [32] Efficacy of finerenone in reducing heart failure outcomes in patients with history of heart failure: A meta-analysis of randomized controlled trials
    Jaiswal, Vikash
    Latif, Fakhar
    Naz, Sidra
    Munnangi, Pragathi
    Deb, Novonil
    Mattupuram, Jishanth
    IJC HEART & VASCULATURE, 2024, 55
  • [33] Effect of survodutide, a glucagon and GLP-1 receptor dual agonist, on weight loss: a meta-analysis of randomized controlled trials
    Wan, Haijun
    Xu, Nuo
    Wang, Lijuan
    Liu, Yaping
    Fatahi, Somaye
    Sohouli, Mohammad Hassan
    Guimaraes, Nathalia Sernizon
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [34] A Systematic Review and Meta-Analysis of Randomized Controlled Trials in Use of GLP-1 Receptor Agonist in Type 1 Diabetes Mellitus
    Panta, Raju
    Kunwar, Sumit
    Batra, Manav
    Ghimire, Dipesh K. C.
    Mudgal, Mayuri
    Makdissi, Antoine
    Chaudhuri, Ajay
    Dandona, Paresh
    DIABETES, 2017, 66 : A308 - A308
  • [35] Impact of Heart Failure History at Baseline on Cardiovascular Effects of GLP-1 Receptor Agonists in Type 2 Diabetes: a Meta-analysis
    Banerjee, Mainak
    Maisnam, Indira
    Mukhopadhyay, Satinath
    CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (04) : 739 - 746
  • [36] Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Qian Zhou
    Xingxing Lei
    Shunlian Fu
    Pan Liu
    Cong Long
    Yanmei Wang
    Zinan Li
    Qian Xie
    Qiu Chen
    Diabetology & Metabolic Syndrome, 15
  • [37] Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Zhou, Qian
    Lei, Xingxing
    Fu, Shunlian
    Liu, Pan
    Long, Cong
    Wang, Yanmei
    Li, Zinan
    Xie, Qian
    Chen, Qiu
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [38] Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials
    Wong, Hon Jen
    Sim, Bryan
    Teo, Yao Hao
    Teo, Yao Neng
    Chan, Mark Y.
    Yeo, Leonard L. L.
    Eng, Pei Chia
    Tan, Benjamin Y. Q.
    Sattar, Naveed
    Dalakoti, Mayank
    Sia, Ching-Hui
    DIABETES CARE, 2025, 48 (02)
  • [39] Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
    Kristensen, Soren L.
    Rorth, Rasmus
    Jhund, Pardeep S.
    Docherty, Kieran F.
    Sattar, Naveed
    Preiss, David
    Kober, Lars
    Petrie, Mark C.
    McMurray, John J. V.
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (10): : 776 - 785
  • [40] Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trial
    Lee, Matthew M. Y.
    Kristensen, Soren L.
    Gerstein, Hertzel C.
    McMurray, John J., V
    Sattar, Naveed
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (01)